UNSPSC 51162028: Ephedrine/secobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162028 Ephedrine/secobarbital is a Commodity code that nominally designates a specific pharmaceutical product, but recent state and local solicitations tagged to this code show minimal alignment with that narrow scope. The code appears in a disparate set of healthcare procurement activities spanning naloxone distribution, on-site pharmacy services management, direct-to-manufacturer prescription programs, and multi-source generic pharmaceutical contracting—none of which center on ephedrine or secobarbital as primary deliverables. State and local health departments, county government health centers, and cooperative purchasing alliances are the issuing bodies, but the actual procurement activity reflects broader pharmacy benefit management, medication supply chain, and healthcare services contracting rather than acquisition of the specific controlled substances the code nominally describes.

Geographic activity includes Florida, Georgia, Texas, and Minnesota based on recent postings. Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems with a July 26, 2026 response deadline; Hall County, Georgia posted an RFQ/P in May 2026 for on-site pharmacy services at its Family Health Center with a June 4, 2026 deadline; the Texas Health and Human Services Commission released an RFI in April 2026 to explore direct-to-manufacturer prescription models; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 deadline. The code's apparent tagging mismatch with actual procurement scope suggests limited relevance for vendors seeking opportunities directly aligned with controlled pharmaceutical substances; activity under this code reflects state and local government's broader healthcare supply chain and pharmacy service management rather than ephedrine or secobarbital procurement specifically.